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Abstract 
Background 
Health anxiety (HA), or hypochondriasis, is a psychological problem characterised by a 
preoccupation with the belief that one is physically unwell. A 2007 Cochrane Review 
(Thomson & Page, 2007) found Cognitive Behavioural Therapy (CBT) to be an effective 
intervention for individuals with HA. Similar findings were reported in a recent meta-analysis 
(Olatunji et al., 2014), which did not employ a systematic search strategy.  
Aims 
The current review aimed to investigate the efficacy of CBT for HA, and to update the 
existing reviews. 
Method 
A systematic search was conducted following PRISMA guidance, including Randomized 
Control Trials that compared CBT with a control condition for people with HA. Five hundred 
and sixty-seven studies were found in the original search, of which 14 were included in the 
meta-analysis.  
Results  
Meta-analysis was conducted on 21 comparisons and a large effect size for CBT compared to 
a control condition was found at post therapy d= 1.01, 95% CI [0.77-1.25], as well as at 6- 
and 12- month follow up.  
Conclusions 
This systematic review and meta-analysis provides support for the hypothesis that CBT is an 
effective intervention for HA when compared to a variety of control conditions, e.g., 
treatment-as-usual, waiting list, medication, and other psychological therapies. 
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1. Introduction 
Hypochondriasis in DSM-IV has been redefined in DSM-5 to Illness Anxiety Disorder (2013, 
American Psychiatric Association). By both definitions, this problem is characterised by 
preoccupation with the belief that one has, or could acquire, a serious illness, emanating from 
“anxiety about the meaning, significance or cause” of their symptoms. This is accompanied 
by high anxiety about health and excessive health-related behaviours or maladaptive 
avoidance. For some time now, these problems have been referred to as “Health Anxiety” 
(HA), and given the recent publication of DSM-5, this is the term used here.  
HA is a common mental health problem; epidemiological studies report rates of 0.26-8.5% of 
individuals in primary care meeting DSM or ICD criteria (Creed & Barsky, 2004). Gureje, 
Ustun & Simon (1997) found that individuals with abridged, or subclinical, HA had similar 
levels of impairment in terms of occupational role, physical impairment and health perception 
to those who met the full ICD-10 criteria. Warwick and Salkovskis (1990) have suggested 
that HA is best thought of as a continuum, with full clinical diagnosis at the upper end. 
Treatment options exist for those experiencing significant distress as a result of their anxiety, 
notably those in the new category of Somatic Symptom Disorder. HA is costly due to the 
over-use of medical health services by individuals with HA and due to comorbidity (Barsky, 
Orav & Bates, 2005; Simon, Gureje, & Fullerton, 2001). There is evidence that rates of HA 
are higher in individuals with physical health conditions (Robbins & Kirmayer, 1996) and 
therefore individuals with medical conditions are an important group to target for treatment. 
 
A cognitive behavioural understanding of HA (Warwick & Salkovskis, 1990) has resulted in 
the development of a focused treatment (Salkovskis, Warwick, & Deale, 2003) which has 
been tested in single cases (Salkovskis & Warwick, 1986), case series (Warwick & Marks, 
1988), and randomised controlled trials (Clark et al., 1998).  The CBT approach to HA 
involves developing a shared understanding of the problem followed by belief and behaviour 
change through discussion, socratic questioning and “behavioural experiments” (Salkovskis, 
Warwick, & Deale, 2003). CBT interventions for HA based on these treatment elements have 
been found to be more effective in RCTs than a stress management package (Clark et al., 
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1998), waiting-list control (Warwick, Clark, Cobb, & Salkovskis, 1996), paroxetine (Greeven 
et al., 2007), and treatment as usual (Barsky & Ahern, 2004).   
In 2007, a Cochrane review was published of psychological therapies for HA (Thomson & 
Page, 2007). This found that psychological therapies for HA were more effective than control 
conditions, with the exception of psycho-education interventions. Whilst a more recent 
review by Olatunji et al. (2014) noted similar findings, there were a number of 
methodological concerns – primarily that the search strategy was not systematic or clearly 
defined. The present systematic review and meta-analysis aimed to update this important 
field by investigating the efficacy of CBT for clinical and subclinical HA relative to control 
conditions, focusing on measures of health anxiety, depression and anxiety pre and post 
intervention, and assessing the quality of the RCTs. A second aim was to investigate whether 
CBT has equivalent effects for subclinical HA compared to clinical HA, and similarly 
whether effects are different for people with medical illness compared to those without.  
2. Method  
 
2.1 Eligibility criteria 
 
2.1.1. Study Type 
Randomised controlled trials of CBT for people with HA were selected for this review. The 
interventions included were problem-specific cognitive behaviour therapy, cognitive therapy, 
or behaviour therapy, including psycho-educational approaches using CBT models and 
strategies delivered 1:1, in groups, or online by trained therapists. Only studies that compared 
CBT with a non-CBT based control condition were included. Control conditions included wait-
list, treatment as usual (TAU), medication, placebo, other psychological therapies, support 
groups, and non CBT psychoeducation.  
 
2.1.2. Population 
Participants were over the age of 18 years, with hypochondriasis diagnosed according to 
standardised diagnostic criteria (e.g. DSM-III, DSM-IV, IV-TR, ICD-10), or with subclinical 
HA measured by a valid HA psychometric measure, not including somatisation disorder. 
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2.1.3. Outcome measurement 
The primary outcome measure was HA symptom severity. Assessments of HA had to use valid 
and reliable questionnaires at pre- and post-therapy. Where a post-therapy measure was not 
available, the next available measure following the end of therapy was used in its place. Six- 
and 12-month follow up measures were also extracted where available. Secondary outcome 
measures of depression and general anxiety for pre- and post-therapy were also included.  
 
2.2 Information sources and study selection 
 
Studies were identified through searching the following databases: Psycinfo, PubMed, 
EBSCO, Embase and Web of Knowledge. The search was conducted on 5 January 2014. A 
second search, using the same criteria, was conducted by one member of the research team on 
6 July 2015 to check for any literature published since the initial search. No new studies 
meeting the inclusion criteria were identified in the second search.  
 
2.2.1 Search 
The search terms used were “Health anxiety” OR hypochondria* AND “cognitive therapy” OR 
“behaviour therapy” OR “behavior therapy” OR “cognitive behaviour therapy” OR “cognitive 
behavior therapy”. These terms were searched in key words, title, abstract, and as MeSH 
subject heading terms. The search was for studies published between 1979 and 2014, to match 
the use of DSM-III and DSM-IV diagnostic criteria.  
 
The reference sections of all included papers, as well as three previous reviews and meta-
analyses (Thomson & Page, 2007; Olatunji et al, 2014;  Bouman, 2014), were scrutinised for 
any overlooked papers. Emails were sent to experts in the field to search for any unpublished 
literature.  
 
2.2.2 Study selection 
After removing duplicates, two members of the research team individually assessed each of the 
remaining papers for inclusion eligibility. This was done in two stages, looking first at just the 
title and abstract, and then at the full text. An a priori procedure was followed to resolve any 
inter-rater discrepancies: in the case of a disagreement about the inclusion of a particular study, 
both reviewers re-assessed the paper for inclusion. If the reassessment still led to a 
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disagreement between the reviewers, an independent third party was asked to assess the paper, 
and the decision would be based on the majority decision.  
 
2.2.3 Data items  
The following was collected from each included paper by one of the authors: details of CBT 
treatment delivered (e.g., length, theoretical orientation, mode of delivery, additions to therapy 
such as psycho-educational material); details of control or second active treatment; participant 
drop out; assessment of health anxiety; presence of physical health conditions and socio-
demographics of participants. The primary dependent variable was a validated measure of 
health anxiety, and secondary outcomes were measures of depression and general anxiety. 
Quality of life was also considered as a secondary outcome, but eventually not included 
because very few studies identified measured this. 
 
2.2.4. Data Extraction 
A data extraction spreadsheet was designed for the purpose of this study, piloted on one of the 
included papers and modified to suit the review questions. This information was extracted from 
each study by a member of the research team. The data to be meta-analysed was checked by a 
second member of the team for accuracy. This included the means and standard deviations 
(SDs) for outcome measures of HA at pre and post treatment, as well as at 6-month and 12-
month follow-ups where available, for each group. Where available, the means and SDs for 
measures of depression and anxiety pre- and post-treatment were also checked. An a priori 
process was followed for this: the completed table was presented to the second team member, 
who highlighted any data points that they disagreed with. The first team member then checked 
the alleged error, and if they agreed with the second team member, changed the error. In the 
case that there was still a disagreement, a third team member would be consulted and the 
majority decision followed. 
 
2.3. Quality assessment  
 
Adopting The Cochrane Collaboration’s tool for assessing bias, an assessment of study quality 
was also conducted. Each of the eligible papers was assessed according to seven different 
domains, which might introduce bias: sequence generation, allocation concealment, blinding 
of participants and personnel, blinding of outcome assessment, incomplete outcome data, 
 
 
CBT for Health Anxiety: Meta-analysis 
selective outcome reporting and ‘other issues’ (Higgins et al., 2011). This information was 
extracted from each included paper by one member of the research team only. An overall rating 
for the quality of each individual study was calculated by allotting a score of three points for 
each of the items rated as having a low risk of bias, two for each item rated as having an unclear 
risk of bias, and one for items rated as having a high risk of bias. A cut-off of the median bias 
scores was used, and studies which scored above the median score were rated as having an 
overall lower risk of bias and those below the median were rated as having a higher risk of 
bias.  
 
2.4 Statistical Analysis 
 
Standardised mean difference effect sizes were calculated for health anxiety, depression, and 
anxiety outcomes where available for pre-therapy, post-therapy and control conditions. In the 
absence of an immediate post-therapy measure, the outcome measures taken the soonest 
following therapy ending were included. Effect sizes for pre therapy and 6-month and 12-
month follow-up HA outcomes were also calculated where possible. 
 
2.4.1 Standardised mean difference  
 
Effect sizes for the difference in outcome between CBT and a control condition, or CBT and a 
second active therapy or medication, were calculated. The pre- and post-therapy outcome 
measures which were used to calculate a change score (post minus pre therapy score) measured 
in Cohen's d – the mean change in outcome measure divided by the pooled SD. A Cohen's d of 
1 means that the two means differed by one SD. To aid interpretation of effect sizes, d=0.2 is 
considered a small effect size, d=0.5 a medium effect size, and d=0.8 a large effect size (Cohen, 
1988). Cohen’s d was selected over Hedge’s g to aid interpretation as Cohen’s d is more widely 
used.  
 
A random-effects meta-analysis is most appropriate when the studies being combined are not 
direct replications of one another, and so was used here due to the heterogeneity of studies in 
terms of types of participants, outcome measures used, and interventions and control conditions 
provided. This model weights each individual effect size inversely proportionally to the sum 
of the variance and heterogeneity. The test of heterogeneity used was the Q test (Cochran, 
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1954), which is the sum of the squared deviations of each study's effect size from the overall 
effect size, with each included effect size being weighted by its inverse variance.   
 
2.4.2 Sub Group analysis 
 
Sub group analysis separated studies which included and excluded participants with physical 
health problems, studies which required a DSM or ICD diagnosis of HA compared to those 
which did not, studies assessed as having low or high risk of bias, and studies with Control 
conditions of either TAU, waitlist or active treatment. 
 
The meta-analysis was conducted for each of these subgroups, and the difference considered 
significant if the confidence intervals of each analysis did not overlap – a conservative 
approach which is recommended in the Cochrane handbook (Higgins & Green, 2008).  
 
 
2.4.3 Bias 
 
Publication bias was assessed using a funnel plot, which plots effect size against standard error 
(as an index of study size), to check if there is evidence for the ‘file drawer problem’ – the idea 
that studies with non-significant results remain unpublished, meaning the literature is biased 
towards presenting positive results. Other things being equal, as many studies should 
overestimate the true effect as underestimate it, and the range of over- and under-estimates 
should be related to the standard error of the study. Specifically, if there is no publication bias, 
then studies with lower error should scatter in a smaller range around the true effect size, 
whereas studies with higher error (and smaller sample sizes) should have a wider range of 
under- and over-estimates, resulting in a “funnel” shaped graph. If the scatter is asymmetrical, 
this may indicate publication bias. In particular, the classic sign of bias is a relative absence of 
studies with low effect sizes and high standard error, as small studies that underestimate the 
utility of the intervention are more likely not to be published.  
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3. Results 
3.1 Study selection 
 
567 articles were identified through database searches, with a further two studies which were 
under review identified as a result of emails to experts in the field. No additional studies were 
identified through the reference lists of included papers. See Figure 1 for a diagrammatic 
representation of the search and selection process, based on the Prisma guidance (Moher, 
Liberati, Tetzlaff, & Altman, 2009).  
 
Of the 344 studies screened for inclusion, 313 were excluded based on detailed examination of 
their title and abstract. The Cohen’s kappa value, which measures the inter-rater agreement 
between the two assessors at this stage of screening, was κ=0.917 (SE=0.041), which is a high 
level of agreement. 31 full-text articles were assessed for their eligibility for inclusion in the 
meta-analysis, and 14 were included in the final study. The Cohen’s kappa coefficient for this 
assessment was κ= 0.933 (SE = 0.065), which again is a high level of agreement. The reasons 
for excluding sixteen papers included: not exclusively recruiting participants with health 
anxiety; not being research papers; not being randomised; including repeat data or follow-up 
data from included studies; not having a non-CBT control condition; not and not using a 
validated measure of HA. 
 
3.2 Study Characteristics 
 
The 14 studies included in the final analysis had a total of 1544 participants. Seven of the 
studies had more than one control or experimental condition, and so 21 comparisons were 
included in the meta-analysis. See Table 1 for summary of participants’ demographic  
information, when this was available. See Table 2 for a summary of the study characteristics. 
 
 
Figure 1. Search process flow chart 
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Table 1. Demographic information for each included study 
 
Study 
Duration 
of HA 
(years) 
Age of 
onset 
(years) 
Gender 
Ratio (% 
of 
female) 
Mean age of 
participant 
(years) 
Marital 
status (% 
married) 
Employment 
(% 
employed) 
Barsky & Ahern 
(2004) 
10.8 31.5 76 42.2  65.7 
Bouman & Visser 
(1998) 
      
Bourgault-Fagnou & 
Hadjistavropoulos 
(2013) 
  77.2 68.7 43.9  
Buwulda et al (2007)       
Clark et al (1998)   67 34   
Greeven et al (2007) 10  58 41.3 68.5  
Hedman et al (2014)    45.5 66.5 54.5 
Hedman et al (2011) 21 22.6 74 39.1  85 
Jones (2002)  50.3     
Seivewright et al 
(2008) 
  47    
Sorensen et al (2011)   63 37 63 74 
Tyrer et al (2014)   53.5 48.7   
Visser & Bouman 
(2001) 
  50 35.6 59 63 
Weck et al (2014)   58 39   
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Table 2. Study characteristics 
Study Diagnostic method 
Physical health 
conditions 
included? 
Trial location 
Risk of bias 
rating 
Barsky & Ahern 
(2004) 50% met DSM-IV No University Low 
Bouman & Visser 
(1998) DSM-IV No Not known Low 
Bourgault-Fagnou & 
Hadjistavropoulos 
(2013) None Yes University High 
Buwulda et al (2007) DSM-IV No Not known Low 
Clark et al (1998) DSM-III-R No Community Low 
Greeven et al (2007) DSM-IV No Hospital High 
Hedman et al (2014) DSM-IV No University  Low 
Hedman et al (2011) DSM-IV No Hospital Low 
Jones (2002) None 
Yes - 50% of 
participants Community High 
Seivewright et al 
(2008) HAI score Yes 
Hospital / 
Community High 
Sorensen et al (2011) ICD-10 No Hospital Low 
Tyrer et al (2014) DSM-IV Yes Hospital High 
Visser & Bouman 
(2001) DSM-IV No  
Community 
and 
University Low 
Weck et al (2014) DSM-IV No University High 
 
 
3.3 Overall meta-analysis results 
 
A meta-analysis of the overall effect of CBT on health anxiety outcome scores, compared to 
all control conditions (21 comparisons: active therapy, waitlist, TAU, medication and placebo 
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medication) was conducted, resulting in a large mean effect size of d= 1.01, 95% CI [0.77-
1.25] – see Figure 2.  
Figure 2. Forest plot of individual and pooled effect sizes of CBT for HA. The vertical line 
represents the null hypothesis position of no effect from CBT. The centre of the diamond 
represents the mean effect size across studies. The error bars on each study’s effect size 
estimate represent the 95% CI. 
 
The heterogeneity analysis was significant (Q = 89.45, p < 0.0001, I² = 75.15), indicating 
substantial heterogeneity between studies. The funnel plot (see figure 3), which plots standard 
error against effect size, was symmetrical and so did not indicate publication bias. A large range 
at the top of the funnel was identified, indicating that studies with lower standard error found 
a wide range of effect sizes, which was not predicted as an increase in precision is expected as 
standard error decreases.  
 
At 6-month follow-up (7 comparisons), a large effect size was again found (d= 0.91, 95% CI 
[0.39-1.44]). The heterogeneity analysis was significant (Q = 35.34, p < 0.0001, I² = 77.16%), 
again showing substantial heterogeneity between studies. The sensitivity analysis revealed that 
removing each study in turn did change the p value, but never to the point of non-significance 
(p ranged from .0001 to .01). 
 
At 12-month follow-up (6 comparisons), a large effect size was still found (d= 1.06, 95% CI 
[0.48-1.63]). The heterogeneity analysis was still significant (p < 0.0001, Q = 31.1, I² = 
76.27%), showing the studies still exhibited substantial heterogeneity. The sensitivity analysis 
revealed that removing each study in turn did change the p value, but not to the point of non-
significance (p ranged from .0001 to .001). 
 
Figure 3. Funnel plot of each study’s standardized effect size against standard error 
 
General anxiety outcome measures at pre- and post- therapy revealed a small effect size (d = 
0.42, 95% CI [0.26-0.58]). The heterogeneity analysis was significant (Q = 29.57, p =0.01, I² 
= 43.6%), representing moderate heterogeneity between studies. The sensitivity analysis 
revealed that removing each study in turn did not change the p value. 
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Depression outcome measures at pre- and post- therapy were also analysed, resulting in a small-
to-medium effect size (d= 0.45, 95% CI [0.31-0.58]). The heterogeneity analysis was not 
significant (Q = 25.43, p =0.11, I² = 23.52%), indicating that the studies produced comparable 
estimates of this effect. The sensitivity analysis revealed that removing each study in turn did 
not change the p value. 
 
3.4 Subgroup analysis 
 
The meta-analysis was conducted several times to analyse the effect of including subgroups. 
Health anxiety outcome measures were compared for studies which included participants with 
physical health problems, and those which excluded physical health problems. In the studies 
including participants with health conditions (k=5), a large effect size was found, d= 1.16, 95% 
CI [0.74-1.58].  A comparably large effect size was also found for studies which excluded 
participants with health conditions k=16, d=0.96, 95% CI [0.67-1.24]. The similarity of these 
two effect sizes, and the overlap of their confidence intervals, suggests that the inclusion of 
participants with physical health conditions did not account for the heterogeneity between 
studies, and also does not significantly impact the efficacy of CBT for HA.  
 
Health anxiety outcomes were compared for studies which required participants to be assessed 
against DSM or ICD criteria before inclusion, versus those which did not. Those which 
included participants without a validated diagnosis (k=5) found a large effect size: d= 1.19, 
95% CI [0.66-1.71]. Studies which required a validated diagnosis (k=16) also had a large effect 
size: d= 0.96, 95% CI [0.70-1.22]. The comparable effect size measures suggest that CBT is 
an effective intervention for both subclinical and clinical levels of HA.  
 
Health anxiety outcomes were compared between studies, which were identified as having a 
low and high risk of bias. Both low and high risk studies were found to have a large effect size 
and significant heterogeneity. High risk studies (k=10) had a mean d of 0.85, 95% CI [0.52-
1.18], and significant heterogeneity (Q = 22.83, p<0.01, I² = 55.5%). Low risk studies (n=11) 
had a large effect size (d=1.13, 95% CI [0.81-1.45]) and significant heterogeneity (p<0.0001, 
Q = 66.40, I² = 81.7%). Again, the overlapping ranges suggest the two sets of studies were 
comparable.  
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Subgroup analysis was conducted on the different types of control groups that CBT was 
compared with: treatment as usual (TAU), waitlist, and an active control (psychological 
therapy, psychosocial support, medication and placebo). A large effect size was found when 
CBT was compared to waitlist (k=10; d=1.45, 95% CI [1.13-1.77], with significant 
heterogeneity (Q = 18.4, p<0.05, I² = 44.7%). A significantly smaller effect size was found 
when CBT was compared to TAU (k=4; d=0.76, 95% CI [0.6-0.92]), and the heterogeneity 
analysis was not significant (Q = 0.55, p = 0.91, I2=0.0%). A medium effect size, not reliably 
different from the waitlist comparison, was found when CBT was compared to other active 
treatments (k=7; d=0.71, 95% CI [0.26-1.16]), and the test for heterogeneity was significant (Q 
= 41.13, p<0.0001, I² = 82.25%).  
4. Discussion 
4.1 Summary of results  
 
The analysis suggested the effect of CBT on health anxiety, compared to the full range of 
control conditions, was positive and substantial, with a mean change in symptoms of 1.01 
standard deviations. There was, however, significant heterogeneity between the included 
studies, which was expected given the range of participants, study protocols and outcome 
measures employed between the RCTs. There was no evidence of publication bias that might 
affect our estimate of the overall effect and subgroup analysis revealed no effect of medical 
condition, formal diagnosis, or study quality on the effect size estimate. CBT performed better 
when compared to waitlist than when compared to TAU, which is perhaps unsurprising given 
that waitlist is the least active of all the control conditions in the included RCTs. 
 
4.2 Comparison to previous reviews 
 
This study updates the results of the previous reviews conducted by Thomson and Page (2007) 
and Olatunji et al. (2014). Although the more recent review by Olatunji et al. (2014) similarly 
found a large effect of CBT for HA immediately post therapy, the methodology of that study 
leaves room for doubt. The present review excluded RCTs that recruited people with medically 
unexplained symptoms, who represent a distinct diagnostic category, but these were included 
in the Olatunju et al. (2014) review. The systematic search strategy and more recent search date 
meant that the current review included five RCTs, which were not included in the Olatunji et 
al. (2014) paper (Clark et al., 1998; Jones, 2002; Tyrer et al., 2014; Weck et al., 2014; Hedman 
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et al., 2014). It is important that the inclusion criteria were narrowed and that recent RCTs were 
included because this increases the validity of results. This review therefore provides robust 
evidence that CBT is an effective intervention for HA, and that it also has a small effect on 
secondary outcomes such as depression and anxiety.  
Our finding a large effect size for CBT immediately following therapy adds to the results of 
the Cochrane review conducted by Thomson and Page (2007), who found that CBT approached 
– but fell short of – a significant effect size for HA outcomes immediately after therapy. The 
difference between the two reviews could be due to the smaller number of studies available to 
meta-analyse at the time of their search in 2005. Alternatively, it could be the quality of RCTs 
has improved, with the disambiguation of the difference between medically unexplained 
symptoms and HA in the DSM 5, and increased research and understanding of the maintaining 
factors for HA.  
 
In terms of secondary outcome measures, the present study found small effect sizes for the 
effect of CBT for HA on depression and generalized anxiety at pre and post therapy. This is 
consistent with both Olatunji et al. (2014) and Thomson and Page (2007). These changes in 
secondary outcomes could indicate the generalised, non-specific benefits of a problem-specific 
intervention, which are perhaps less influenced by factors such as the conflation of medically 
unexplained symptoms and HA (as was apparent in the Olatunji meta-analysis), and the size 
and quality of the RCT.  
 
The present review found large effect sizes at 6- and 12-month follow up, as well as 
immediately after treatment. This contrasts with the results of Olatunji et al. (2014), who found 
only a small effect size at follow up. This difference could be due to the well-defined follow-
up measure in the present meta-analysis, with the separation of 6- and 12-month follow-up 
measures. Our finding of sustained benefits up to 12 months is important, because the trajectory 
of effect size over time is an indication of the long term effects of the intervention, and also 
because HA has a low natural recovery rate (olde Hartman et al., 2009). This meta-analysis 
therefore provides support for the long term positive effects of CBT for HA.  
 
4.3 Clinical Implications 
 
Another important finding of the present meta-analysis was that there was no effect of 
including participants with medical illness on the positive outcome of CBT intervention. This 
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group are more likely to experience realistic negative automatic thoughts due to the presence 
of a physical health condition, which in turn might be expected to have negative implications 
for treatment outcome. However, this meta-analysis provides evidence that realistic automatic 
thoughts are not a treatment barrier, and so this group should be offered CBT treatment for 
their HA. Finding that CBT is still an effective intervention for people with physical health 
problems alongside their health related anxiety is important given the higher prevalence of HA, 
and the greater impact on functioning, in this group (Robbins & Kirmayer, 1996).  
  
Another finding from the subgroup analysis was that CBT for HA was effective for people with 
and without a formal diagnosis of HA. This is important given the high percentage of people 
with subclinical HA (Gureje et al., 1997), for whom CBT is revealed here to be a helpful 
intervention. This highlights the importance of providing treatment to individuals who may not 
meet all diagnostic criteria, but who are still experiencing significant distress and decreased 
quality of life, as they are likely to respond to treatment.  
 
A final point of interest is that one RCT included in this review specifically recruited older 
adults with HA (Bourgault-Fagnou & Hadjistavropoulos, 2013). This trial found very large 
effect sizes, larger than any other included RCT, suggesting that CBT is a highly effective 
intervention for older adults with HA.  
 
4.4 Strengths and Limitations 
 
A limitation of this review is the lack of inter-rating for the risk of bias assessment. This could 
lead to less accurate results of the quality assessment, due to human error. The sub-group 
analysis revealed that there was less heterogeneity between the results of studies marked as 
being at high risk of bias compared to those at low risk; this highlights the challenges of 
assessing quality in papers based on a quantitative system drawing on information presented 
by the original authors in their method sections. This also highlights that quality is a difficult 
construct to assess between different papers, and that it may vary depending on the 
methodology – a one-size-fits-all approach to quality assessment may not lead to robust results. 
A decision was made to give a score of quality, in order to be able to analyse high and low 
quality papers separately and see if quality impacted on effect size, as quality could account 
for some of the heterogeneity between studies.  The fact there was no significant difference 
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between the effect sizes in studies with high and low bias suggests that it might be problematic 
to place a numerical score of quality on paper.  
 
Another limitation is the finding that the heterogeneity between included studies was 
significant, but the lack of significant findings from the a-priori subgroup analyses to account 
for this heterogeneity. This is likely to be due to multiple factors in the papers which make 
finding differences between subgroups difficult, e.g. heterogeneity in study design and 
outcome measuring, and the similarity of effects for different therapeutic interventions. In some 
ways this has provided helpful clinical information, e.g. the presence of a physical health 
condition or subclinical HA is not a treatment barrier. At the same time, it does not point to 
RCT features which effect treatment outcome, which would be helpful information in the 
design of future trials.  
 
A strength of this review is the separation of the diagnostic categories of HA and medically 
unexplained symptoms, with only studies that included participants with HA included. This 
increases the validity of the results for people with HA, as medically unexplained symptoms is 
a different psychological problem which requires targeted treatment considerations. As such 
the efficacy of CBT for these conditions should be reviewed separately. The clear definition of 
traditional CBT approaches has also helped to maximise treatment homogeneity across the 
included RCTs, increasing the validity of the results. The inter-rating of all data in the meta-
analysis and the a-priori decisions about how to deal with inter-rater discrepancies increased 
the rigour of the review process and therefore lowered the risk of bias in the meta-analysis 
results.  
 
4.5 Summary 
 
This systematic review and meta-analysis provides clear evidence supporting CBT treatment 
of HA, in people with and without medical problems, and in people with subclinical as well as 
clinical levels of HA. The use of CBT for HA now requires further exploration, to delineate 
the active treatment elements. For example, further investigation is needed into the role of 
cognitive restructuring compared to purely behavioural approaches, and on the role of 
attentional processes within HA and whether these are a key treatment target. Such work would 
continue to refine and develop the problem-specific model of CBT for HA. 
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